Corrective Phases R...
Health Care: Health Services
Baxter International Inc. (BAX: NYSE)
$50.06 -0.11 | -0.22%
06/04/12 - 04:01 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 2.90B | 2.68B | 2.79B | 2.13B |
| Receivables | 2.42B | 2.26B | 2.30B | 1.98B |
| Inventories | 2.63B | 2.37B | 2.56B | 2.36B |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 8.65B | 7.99B | 8.27B | 7.15B |
| Property, Plant & Equipment, Gross | 10.97B | 10.59B | 10.06B | 9.02B |
| Accumulated Depreciation & Depletion | 5.45B | 5.33B | 4.90B | 4.41B |
| Property, Plant & Equipment, Net | 5.52B | 5.26B | 5.16B | 4.61B |
| Intangibles | 826.00M | 500.00M | 513.00M | 390.00M |
| Other Non-Current Assets | 1.76B | 586.00M | 491.00M | 472.00M |
| Total Non-Current Assets | 10.42B | 9.50B | 9.08B | 8.26B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 19.07B | 17.49B | 17.35B | 15.40B |
| Accounts Payable | 795.00M | 745.00M | 807.00M | 829.00M |
| Short Term Debt | 446.00M | 24.00M | 711.00M | 394.00M |
| Other Current Liabilities | 2.09B | 526.00M | 549.00M | 416.00M |
| Total Current Liabilities | 4.86B | 4.04B | 4.46B | 3.64B |
| Long Term Debt | 4.75B | 4.36B | 3.44B | 3.36B |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 2.64B | 2.29B | 2.03B | 2.18B |
| Minority Interest | 32.00M | 7.00M | 10.00M | 0.00 |
| Total Non-Current Liabilities | 7.63B | 6.88B | 5.70B | 5.54B |
| Total Liabilities | 12.49B | 10.92B | 10.16B | 9.18B |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 6.58B | 6.57B | 7.19B | 6.23B |
| Common Par | 683.00M | 683.00M | 683.00M | 683.00M |
| Additional Paid In Capital | 5.78B | 5.75B | 5.68B | 5.53B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 9.43B | 7.92B | 7.34B | 5.80B |
| Treasury Stock | -6.72B | -5.66B | -4.74B | -3.90B |
| Other Equity Adjustments | -2.59B | -2.14B | -1.78B | -1.88B |
| Total Capitalization | 11.33B | 10.93B | 10.63B | 9.59B |
| Total Equity | 6.58B | 6.57B | 7.19B | 6.23B |
| Total Liabilities & Stock Equity | 19.07B | 17.49B | 17.35B | 15.40B |
| Total Common Shares Outstanding | 560.97M | 580.73M | 600.97M | 613.85M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 122.52M | 102.76M | 82.52M | 67.50M |
| Basic Weighted Shares Outstanding | 569.00M | 590.00M | 607.00M | 625.00M |
| Diluted Weighted Shares Outstanding | 573.00M | 594.00M | 614.00M | 637.00M |
| Number of Employees | 48500 | 48000 | 49700 | 48500 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with BAX
- Portfolio NameUser Type
- ProJohn Paulson
- ContributorMost-Searched Stocks for th...
- ContributorTop-Yielding Health Service...
- ProBill Frels - Mairs & Power
- ProHighbridge Capital Management
- ProFarallon Capital Management
- UserDividend Income 2011-11-23
- ProJohn Buckingham - Al Frank ...
- ContributorDividend Stocks for the Wee...
- Contributor9 Stocks With Low Volatilit...
Latest BAX Headlines from TheStreet
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.25.12 | 05:05 pm
- 6 Low-Yield Dividend Captures 05.18.12 | 11:05 am
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.11.12 | 04:05 pm
- 'Mad Money' Lightning Round: Devon's Worth More 04.19.12 | 07:04 pm
- Baxter International's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.19.12 | 02:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 06:04 pm
- Mattel, Endocyte, Ivanhoe Are Market Movers 04.16.12 | 05:04 pm
- 7 Hot Stocks on Traders' Radars 04.16.12 | 03:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 01:04 pm
- 'Mad Money' Lightning Round: Bullish on Baxter 03.27.12 | 07:03 pm
Press Releases for BAX
- Baxter Announces Collaboration With Chatham Therapeutics For Factor IX Hemophilia B Gene Therapy Treatment - Business Wire 06.04.12 | 09:06 am
- Baxter To Present At William Blair & Company 32nd Annual Growth Stock Conference - Business Wire 05.30.12 | 04:05 pm
- Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control In Trials Of Diabetics Undergoing Dialysis - Business Wire 05.25.12 | 03:05 am
- Baxter To Present At Goldman Sachs 33rd Annual Global Healthcare Conference - Business Wire 05.23.12 | 04:05 pm
- Baxter Announces ADVATE Approval In China For The Treatment Of Hemophilia A - Business Wire 05.16.12 | 09:05 am
- Baxter Declares Quarterly Dividend - Business Wire 05.07.12 | 04:05 pm
- Baxter To Present At Bank Of America Merrill Lynch 2012 Healthcare Conference - Business Wire 05.02.12 | 04:05 pm
- Leading Health Economist Mark V. Pauly, Ph.D., Named 2012 Recipient Of The Willam B. Graham Prize For Health Services Research - Business Wire 05.01.12 | 09:05 am
- Baxter Completes Purchase Of Sigma International - Business Wire 04.26.12 | 08:04 am
- Baxter To Present At Deutsche Bank Securities, Inc. 37th Annual Healthcare Conference - Business Wire 04.24.12 | 04:04 pm
Partner Headlines for BAX
- Baxter And Neostem Validating Each Other's Cell Therapies - Seeking Alpha 06.01.12 | 09:06 am
- Stock Analysts Upgraded or Downgraded These Shares on Jun 1st - Wall St. Cheat Sheet 06.01.12 | 04:06 am
- UPDATE: Citi Lowers Baxter's PT - Benzinga 04.20.12 | 09:04 am
- Notable Options Activity in BAX - Benzinga 04.16.12 | 01:04 pm
- Baxter International Inc.: Worth A Look - Seeking Alpha 03.12.12 | 09:03 am
- Haemonetics Reaffirmed at Neutral - Analyst Blog - Zacks 03.02.12 | 06:03 pm
- Boston Scientific Offers Investors Huge Valuation Upside - Seeking Alpha 02.29.12 | 09:02 am
- Significant Upside Of About 25% For Baxter, Covidien - Seeking Alpha 02.24.12 | 05:02 pm
- Mylan Looks To Reap A Harvest Of Patent Expirations - Seeking Alpha 02.22.12 | 09:02 am
- Building A Capital Preservation And Income Portfolio, Part 8 - Seeking Alpha 02.17.12 | 04:02 pm
